FDA Approves First Drug to Treat Dementia-Associated Agitation in AD Patients
U.S. Food and Drug Administration
Individuals who received two mg or three mg of Rexulti showed statistically significant and clinically meaningful improvements
Dementia
Structural Variants Contributing to Non-Alzheimer’s Dementia Identified
National Institutes of Health
Discovery provides potential clues for Lewy body and frontotemporal dementias
New Blood-Based Biomarker to Diagnose Vascular Dementia
UCLA Health
Angiogenic biomarkers could allow clinicians to distinguish Alzheimer's-predominant dementia from significant vascular contribution
Diagnostic Marker Found for Deadly Brain Disease
Washington University School of Medicine
Discovery could accelerate progress toward therapies for primary tauopathies
Scientists Detect Dementia Signs as Early as Nine Years Ahead of Diagnosis
University of Cambridge
The findings could improve screening and help with clinical trial recruitment
A Quick, Easy Scan Can Reveal Late-Life Dementia Risk
Edith Cowan University
A long-term study has shown a common bone density scan can also show if someone is at risk of developing dementia
New Research Identifies Blood Biomarker for Predicting Dementia before Symptoms
National University of Ireland Galway
Researchers point to groundbreaking potential to screen for those at high risk of disease
Increased Fats and Protein Could Provide Diagnosis in Lewy Body Dementia
Newcastle University
This study paves the way towards sensitive and accurate testing for the disease
White Matter Lesion Mapping Tool Identifies Early Signs of Dementia
NYU Langone Health
The new tool can analyze tissue damage seen on MRI scans to detect early signs of cognitive decline
ALS and Frontotemporal Dementia: Early Diagnosis Thanks to an Experimental Test
Scuola Internazionale Superiore di Studi Avanzati
Researchers identify the protein TDP-43 as a potential biomarker of ALS and frontotemporal dementia